Biocause Pharmaceutical to Increase Shares in Domestic Stock Market

Biocause Pharmaceutical to Increase Shares in Domestic Stock Market

导出

摘要 Hubei Biocause Pharmaceutical Co.,Ltd.(Biocause Pharmaceutical,SZ:000627) announced on January 3rd its scheme for the non-publicoffering has been approved by China Securities Regulatory Commission.The company plans to issue up to 82 million domestic shares,at

出处《China Chemical Reporter》 2008年第3期10-10,共4页 中国化工报导（英文版）

关键词 SHARES HUBEI approved SECURITIES thousand RESINS e

分类号 F426.72 [经济管理—产业经济]

引文网络
相关文献

1Sinopec Regroups Wuhan Petroleum[J].China Chemical Reporter,2008(23):5-5.
2西伯利亚矿业发换股债券[J].经济导报,2009(35):42-42.
3韩国业界预测钢铁价格将在明年秋季回升[J].船舶物资与市场,2008(6):10-10.
4Hailide to List in Stock Market[J].China Chemical Reporter,2008(3):10-10.
5Shenyang Chemical Increases Shares[J].China Chemical Reporter,2008(3):9-9.
6Are Farmers Ready for the Stock Market?[J].Beijing Review,2010,53(20):46-47.
7Yuanxing Natural Alkali Issues Additional Shares[J].China Chemical Reporter,2008(6):9-9.
8Sinopec Corp.Issues Bonds with Warrants[J].China Chemical Reporter,2008(6):8-8.
9羽冬.2006年全球半导体资本支出将增长13.4%[J].半导体信息,2006,0(2):11-11.
10Yunwei's Issuing New Shares Approved[J].China Chemical Reporter,2008(27):9-9.

China Chemical Reporter

2008年第3期

浏览历史

内容加载中请稍等...

Biocause Pharmaceutical to Increase Shares in Domestic Stock Market

相关作者

相关机构

相关主题

浏览历史